Search Within

Ellen Marlese Basu

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (7)
Groups
  1. Center for Molecular Imaging and Biotechnology (25)
  2. GSK Faculty (25)
  3. Neuroblastoma Service (25)
  4. Pediatrics, Department of (25)
  5. Tow Center for Developmental Oncology (TCDO) (25)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (23)

More Groups

People
  1. Brian Kushner (25)
  2. Shakeel Modak (25)
  3. Stephen Roberts (24)
  4. Nai-Kong Cheung (23)
  5. Audrey Mauguen (7)
  6. Irene Cheung (4)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (3)
  5. 2019 (9)
  6. 2018 (1)

More Years

Publications
  1. Pediatric Blood and Cancer (14)
  2. International Journal of Radiation Oncology, Biology, Physics (3)
  3. Journal of Clinical Oncology (3)
  4. JAMA Oncology (2)
  5. Cancer Research (1)
  6. Frontiers in Oncology (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (14)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (3)
  4. American Medical Association (2)
  5. American Association for Cancer Research (1)
  6. Frontiers Media S.A. (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease
    Journal Article

    Fong, C.; Kushner, B. H.; Di Giannatale, A.; Gundem, G.; Li, S.; Roberts, S. S.; Basu, E. M.; Price, A.; Cheung, N. K. V.; Modak, S.
    Frontiers in Oncology (2023)

    Fulltext@MSK | Save
  • Plasma cell-free DNA analysis uncovered tumor heterogeneity and clonal evolution during treatment for relapsed neuroblastoma
    Meeting Abstract

    Cardenas, F. I.; Kothari, P.; Tsui, D.; Basu, E.; Roberts, S.; Cheung, N. K.; Kushner, B.; Modak, S.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Skeletal muscle metastases in neuroblastoma: An ostensible "forme fruste" of stage MS disease
    Meeting Abstract

    Fong, C.; Kushner, B.; Di Giannatale, A.; Roberts, S.; Basu, E.; Price, A.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
    Meeting Abstract

    Shahid, S.; Kushner, B.; Modak, S.; Basu, E.; Rubin, E.; Gundem, G.; Papaemmanuil, E.; Roberts, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
    Journal Article

    Shahid, S.; Kushner, B. H.; Modak, S.; Basu, E. M.; Rubin, E. M.; Gundem, G.; Papaemmanuil, E.; Roberts, S. S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Favorable toxicity profile of bivalent GD2/GD3 neuroblastoma vaccine
    Meeting Abstract

    Modak, S.; Cheung, N. K.; Basu, E.; Roberts, S.; Kushner, B.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save